National and Kapodistrian University of Athens, Department of Cardiac Surgery, Athens, Greece; Department of Cardiac Surgery, Mouwasat Hospital, Dammam, Saudi Arabia.
2bull MeDiTherapy P.C., Patra, Greece.
Hellenic J Cardiol. 2022 Mar-Apr;64:15-23. doi: 10.1016/j.hjc.2021.10.001. Epub 2021 Nov 3.
Risk algorithms for the prediction of long-term survival after coronary artery bypass grafting (CABG) do not include the use of bilateral internal thoracic artery (BITA) grafting among the independent predictors. We sought to reveal the superiority of BITA grafting in the long-term outcome through the lenses of an existing bedside risk score (BRS).
This study analyzed data from 5,666 consecutive patients undergoing isolated (n = 4,715 - BITA = 2,792) and combined (n = 951 - BITA = 246) CABG. The mean follow-up period was 10.3 years (interquartile range, 9.9 years). All the predictors of an existing BRS were available for analysis (age, body mass index, ejection fraction, unstable hemodynamic state, left main disease, cerebrovascular disease, peripheral arterial disease, congestive heart failure, malignant ventricular arrhythmia, chronic obstructive pulmonary disease, diabetes, and previous heart surgery). Furthermore, a modified BRS was constructed taking into account the use of BITA grafting and combined CABG.
The good discriminatory ability and satisfactory calibration of the BRS was confirmed in the isolated CABG subgroup. The modified BRS showed improved discriminatory ability and similar calibration. It showed a time-varying coefficient, and accordingly, we calculated the adjusted survival predictions up to 20 years after isolated and combined CABG with or without BITA grafting. Patients with BITA grafting in the low-risk quartile showed 68.4% and 65.5% predicted survival rates at 20 years in the isolated and combined CABG subgroups, respectively, versus the survival rates of 56.4% and 52.8% observed among patients without BITA grafting.
The modified BRS is a useful simplified algorithm for clinicians in choosing treatment intervention for severe isolated or combined coronary artery disease. We clearly demonstrated the superiority of BITA grafting in long-term survival throughout the entire range of the modified BRS.
用于预测冠状动脉旁路移植术后(CABG)长期生存的风险算法并未将双侧内乳动脉(BITA)搭桥术作为独立预测因素。我们试图通过现有的床边风险评分(BRS)来揭示 BITA 搭桥术在长期结果中的优势。
本研究分析了 5666 例连续接受单纯(n=4715,BITA=2792)和复合(n=951,BITA=246)CABG 的患者数据。平均随访时间为 10.3 年(四分位距,9.9 年)。可分析现有 BRS 的所有预测因素(年龄、体重指数、射血分数、不稳定的血流动力学状态、左主干疾病、脑血管疾病、外周动脉疾病、充血性心力衰竭、恶性室性心律失常、慢性阻塞性肺疾病、糖尿病和既往心脏手术)。此外,构建了一个考虑到 BITA 搭桥术和复合 CABG 使用的改良 BRS。
在单纯 CABG 亚组中,确认了 BRS 的良好区分能力和令人满意的校准。改良的 BRS 显示出更好的区分能力和相似的校准。它显示出时变系数,因此,我们计算了在有无 BITA 搭桥术的情况下,单纯和复合 CABG 术后 20 年内的调整后的生存预测。在低风险四分位的 BITA 搭桥术患者中,单纯和复合 CABG 亚组分别有 68.4%和 65.5%的预测生存率,而无 BITA 搭桥术的患者生存率分别为 56.4%和 52.8%。
改良的 BRS 是临床医生在选择严重孤立或复合冠状动脉疾病治疗干预措施的有用简化算法。我们清楚地证明了 BITA 搭桥术在整个改良 BRS 范围内在长期生存中的优势。